25 Years of Proton Pump Inhibitors: A Comprehensive Review
Author:
Affiliation:
1. Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA
2. Division of Gastroenterology, Daegu Fatima Hospital, Daegu, Korea
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2017/011/ekjg011-01-08.pdf
Reference102 articles.
1. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: A double-blind, randomized clinical trial
2. Huang, JQ, and Hunt, RH (1996). pH, healing rate and symptom relief in acid-related diseases. Yale J Biol Med. 69, 159-174.
3. U.S. Food and Drug Administration (2014). Proton pump inhibitors: US Food and Drug Administration-approved indications and dosages for use in adults [Internet].[cited 2016 Aug 31]. Available from: http://www.fda.gov/drugs
4. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
5. Lassen, AT (2007). Acid-related disorders and use of antisecretory medication. Dan Med Bull. 54, 18-30.
Cited by 411 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Meta-Analysis;Current Diabetes Reviews;2024-10
2. Characterization of intestine-specific TRPM6 knockout C57BL/6 J mice: effects of short-term omeprazole treatment;Pflügers Archiv - European Journal of Physiology;2024-09-13
3. Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians;Expert Review of Cardiovascular Therapy;2024-09-12
4. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11
5. Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails;Frontiers in Nutrition;2024-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3